Table 3.
Effects of arginine on casein synthesis in LPS-treated BMECs.
| Con (DMEM/F12 medium) |
Arg (100 µg/mL) |
LPS (10 µg/mL) |
Arg + LPS (100 µg/mL + 10 µg/mL) |
|
|---|---|---|---|---|
| α-Casein (µg/mL) | 164.91 ± 2.89a | 179.80 ± 4.33b | 150.49 ± 6.70a | 155.90 ± 1.73a |
| β-Casein (µg/mL) | 75.10 ± 2.41bc | 82.29 ± 5.87c | 52.25 ± 3.22a | 67.38 ± 1.62b |
| κ-Casein (µg/mL) | 24.66 ± 4.82 | 27.07 ± 5.02 | 19.89 ± 7.60 | 21.77 ± 2.86 |
| Total casein1 (µg/mL) | 264.67 ± 0.89b | 289.16 ± 1.39c | 222.62 ± 11.03a | 255.37 ± 7.83b |
1Total casein = α-casein + β-casein + κ-casein.
Values are expressed as mean ± SEM, n = 3. Mean with different letters differ (a, b, or c) are significantly different (P < 0.05) from each other.